Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06468618 · ClinicalTrials.gov registry record · NA

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

A NA study of Sleep Disturbance and Stem Cell Transplant Complications, sponsored by Dana-Farber Cancer Institute.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT06468618: Recruiting NA study of Sleep Disturbance and Stem Cell Transplant Complications, sponsored by Dana-Farber Cancer Institute.

NCT06468618 is a NA study of Sleep Disturbance and Stem Cell Transplant Complications that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants, below the 178-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06468618, a NA study of Sleep Disturbance and Stem Cell Transplant Complications, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.

Primary Outcome

Defined as the proportion of eligible participants approached by research staff and consent to participate in the study with the cutoff set at ≥30% of eligible participants that are approached and agree to participate.

Interventions

  • BEHAVIORAL DREAMS Program Video and Care Kit

Study Locations (2)

Massachusetts

  • Boston Children's Hospital - Boston
  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-08-06
Est. Completion 2026-08
Phase NA
Dana-Farber Cancer Institute

781 total trials

What NCT06468618 shows while recruiting

NCT06468618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 178-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 1 intervention - of which DREAMS Program Video and Care Kit is the first listed.

NCT06468618 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06468618 about?

NCT06468618 is a clinical study titled "Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients". Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot ...

What is the current status of trial NCT06468618?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-08-06. Estimated completion is 2026-08.

What conditions does trial NCT06468618 study?

This clinical trial studies the following conditions: Sleep Disturbance, Stem Cell Transplant Complications.

What interventions are being tested in trial NCT06468618?

The interventions under investigation include: DREAMS Program Video and Care Kit (BEHAVIORAL).

Who is sponsoring clinical trial NCT06468618?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06468618 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disturbance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06468618's enrollment target sits among peer trials

10 56th of 56 the lowest of 56 other Sleep Disturbance trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06468618, the US trial registry maintained by the National Library of Medicine. NCT06468618 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.